إعلان
إعلان

HCA

HCA logo

HCA Healthcare, Inc.

466.69
USD
برعاية
-6.57
-1.39%
٣١ ديسمبر, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

466.60

-0.10
-0.02%

تقارير أرباح HCA

النسبة الإيجابية المفاجئة

HCA تفوق 26 من 39 آخر التقديرات.

67%

التقرير التالي

بيانات التقرير القادم
٢٢ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$19.86B
/
$7.50
التغير الضمني من Q3 25 (Revenue/ EPS)
+3.66%
/
+7.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
+8.63%
/
+33.21%

HCA Healthcare, Inc. earnings per share and revenue

On ٢٤ أكتوبر ٢٠٢٥, HCA reported earnings of 6.96 USD per share (EPS) for Q3 25, beating the estimate of 5.77 USD, resulting in a 20.55% surprise. Revenue reached 19.16 مليار, compared to an expected 18.75 مليار, with a 2.21% difference. The market reacted with a +1.56% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 23 analysts forecast an EPS of 7.50 USD, with revenue projected to reach 19.86 مليار USD, implying an increase of 7.76% EPS, and increase of 3.66% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, HCA Healthcare, Inc. reported EPS of $6.96, beating estimates by 20.55%, and revenue of $19.16B, 2.21% above expectations.
The stock price moved up 1.56%, changed from $440.16 before the earnings release to $447.04 the day after.
The next earning report is scheduled for ٢٢ يناير ٢٠٢٦.
Based on 23 analysts, HCA Healthcare, Inc. is expected to report EPS of $7.50 and revenue of $19.86B for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان